Literature DB >> 11009087

The herpes simplex virus type 1 Fc receptor discriminates between IgG1 allotypes.

A Atherton1, K L Armour, S Bell, A C Minson, M R Clark.   

Abstract

Herpes simplex virus type 1 (HSV-1) expresses a complex of two virally encoded glycoproteins, gE and gl, which is capable of binding nonimmune human IgG. The gE-gl complex has thus become known as an Fc receptor (FcR), which reportedly binds human IgG subclasses in the order IgG4 > IgG1 > or = IgG2 and does not bind IgG3 from many individuals. There is, however, allelic variation in the genes encoding the human IgG1 heavy chain constant region and this gives rise to allotypes of IgG1. Using recombinant monoclonal IgG molecules of known isotype and mutants thereof we have unexpectedly discovered that the HSV-1 FcR discriminates between IgG1 allotypes. This is evidence of functional differences between IgG1 allotypes that may account for their distribution in populations. Furthermore, these findings suggest HSV-1 FcR binding sites on the IgG molecule some distance from the proposed binding site in the CH2-CH3 domain interface.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11009087     DOI: 10.1002/1521-4141(200009)30:9<2540::AID-IMMU2540>3.0.CO;2-S

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  21 in total

1.  Immunoglobulin genes and immunity to herpes simplex virus type 1.

Authors:  Janardan P Pandey
Journal:  J Infect Dis       Date:  2012-04-25       Impact factor: 5.226

2.  Immunoglobulin G genotypes and the risk of schizophrenia.

Authors:  Janardan P Pandey; Aryan M Namboodiri; Robert C Elston
Journal:  Hum Genet       Date:  2016-07-08       Impact factor: 4.132

3.  Genetic markers of immunoglobulin G and immunity to cytomegalovirus in patients with breast cancer.

Authors:  Janardan P Pandey; Aryan M Namboodiri; Sarumathi Mohan; Paul J Nietert; Lindsay Peterson
Journal:  Cell Immunol       Date:  2016-11-02       Impact factor: 4.868

4.  IGHG, IGKC, and FCGR genes and endogenous antibody responses to GARP in patients with breast cancer and matched controls.

Authors:  Janardan P Pandey; Aryan M Namboodiri; Kent E Armeson; Motoki Iwasaki; Yoshio Kasuga; Gerson S Hamada; Shoichiro Tsugane
Journal:  Hum Immunol       Date:  2018-06-04       Impact factor: 2.850

5.  Immunoglobulin genotypes and cognitive functions in schizophrenia.

Authors:  Janardan P Pandey; Aryan M Namboodiri; Paul J Nietert; Reiji Yoshimura; Hikaru Hori
Journal:  Immunogenetics       Date:  2017-09-22       Impact factor: 2.846

6.  The decoy Fcγ receptor encoded by the cytomegalovirus UL119-UL118 gene has differential affinity to IgG proteins expressing different GM allotypes.

Authors:  Janardan P Pandey; Aryan M Namboodiri; Faisal F Radwan; Paul J Nietert
Journal:  Hum Immunol       Date:  2015-09-14       Impact factor: 2.850

7.  Immunoglobulin genes and the acquisition of HIV infection in a randomized trial of recombinant adenovirus HIV vaccine.

Authors:  Janardan P Pandey; Aryan M Namboodiri; Shizhong Bu; Jean De Dieu Tapsoba; Alicia Sato; James Y Dai
Journal:  Virology       Date:  2013-04-11       Impact factor: 3.616

8.  Fc gamma receptor-like hepatitis C virus core protein binds differentially to IgG of discordant Fc (GM) genotypes.

Authors:  Aryan M Namboodiri; Agata Budkowska; Paul J Nietert; Janardan P Pandey
Journal:  Mol Immunol       Date:  2007-05-07       Impact factor: 4.407

9.  Association between γ marker, human leucocyte antigens and killer immunoglobulin-like receptors and the natural course of human cytomegalovirus infection: a pilot study performed in a Sicilian population.

Authors:  Danilo Di Bona; Giulia Accardi; Anna Aiello; Massimo Bilancia; Giuseppina Candore; Claudia Colomba; Calogero Caruso; Giovanni Duro; Caterina M Gambino; Luigi Macchia; Janardan P Pandey
Journal:  Immunology       Date:  2017-12-11       Impact factor: 7.397

10.  An Ig γ Marker Genotype Is a Strong Risk Factor for Alzheimer Disease, Independent of Apolipoprotein E ε4 Genotype.

Authors:  Janardan P Pandey; Jan Olsson; Bodil Weidung; Ronald T Kothera; Anders Johansson; Sture Eriksson; Göran Hallmans; Fredrik Elgh; Hugo Lövheim
Journal:  J Immunol       Date:  2020-07-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.